NBY - NovaBay reports 2Q19 revenue July, 29 2019 06:59 AM NovaBay Pharmaceuticals Inc. NovaBay (NYSEMKT:NBY): Q2 revenue of $1.8M (-39.0% Y/Y) beats by $0.27M.The company will report its 2Q19 results on 8th August, 2019.Press ReleaseMore news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,